Fatigue and Other Patient-Reported Outcomes in Patients With RRMS who Switched to Ocrelizumab: 4-Year Data From CASTING-LIBERTO

被引：1
作者：
Kister, Ilya [1 ]
Benedict, Ralph [2 ]
Comi, Giancarlo [3 ,4 ]
Cutter, Gary [5 ]
Oreja Guevara, Celia [6 ]
Clinch, Susanne [7 ]
Kuenzel, Thomas [8 ]
Dirks, Petra [8 ]
Vermersch, Patrick [9 ]
机构：
[1] NYU, Multiple Sclerosis Comprehens Care Ctr, Langone Med Ctr, New York, NY USA
[2] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] Casa Cura Policlin, Milan, Italy
[5] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL USA
[6] Hosp Clin San Carlos, Madrid, Spain
[7] Roche Prod Ltd, Welwyn Garden City, England
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
[9] Univ Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202199
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6-3.010
引用
收藏
页数：5
相关论文
共 50 条
  • [31] DUTASTERIDE PLUS TAMSULOSIN PROVIDES SUPERIOR IMPROVEMENTS IN PATIENT-REPORTED QUALITY OF LIFE: 4-YEAR RESULTS FROM THE COMBINATION OF AVODART® AND TAMSULOSIN (COMBAT) STUDY
    Haillot, O.
    Budia, A.
    Wilson, T.
    Black, L.
    VALUE IN HEALTH, 2009, 12 (07) : A290 - A290
  • [32] Recommendations for presenting patient-reported outcomes data to patients and clinicians: results from a modified-Delphi consensus process
    Brundage, Michael
    Bantug, Elissa
    Smith, Katherine C.
    Holzner, Bernhard
    Rivera, Yonaira
    Snyder, Claire
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 96 - 97
  • [33] Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study
    Montorsi, F.
    Henkel, T.
    Geboers, A.
    Mirone, V.
    Arrosagaray, P.
    Morrill, B.
    Black, L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (08) : 1042 - 1051
  • [34] Alemtuzumab reduces the rate of brain volume Loss in RRMS patients who switched from SC IFNB-1a to alemtuzumab (4-Year Follow-Up of the CARE-MS I and II studies)
    Traboulsee, A.
    Pelletier, D.
    Comi, G.
    Rovira, A.
    Schippling, S.
    Margolin, D. H.
    Thangavelu, K.
    Nakamura, K.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 613 - 614
  • [35] Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial
    Strober, B. E.
    Sobell, J. M.
    Duffin, K. C.
    Bao, Y.
    Guerin, A.
    Yang, H.
    Goldblum, O.
    Okun, M. M.
    Mulani, P. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (06) : 1374 - 1381
  • [36] Patient-Reported Outcomes of Maxillary Edentulous Patients Wearing Overdentures Retained by Two Implants from Insertion to 4 Years
    Zembic, Anja
    Tahmaseb, Ali
    Jung, Ronald E.
    Wiedemeier, Daniel
    Wismeijer, Daniel
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2019, 34 (02) : 481 - 488
  • [37] Patient-reported quality of life (QoL) of advanced melanoma patients in a Phase 3 study of nivolumab (NIVO) with or without ipilimumab (IPI) versus IPI: CheckMate 067 4-year data.
    Schadendorf, Dirk
    Larkin, James M. G.
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Taylor, Fiona
    Lawrance, Rachael
    Moreno-Koehler, Alejandro
    Lord-Bessen, Jennifer
    Rizzo, Jasmine I.
    Moshyk, Andriy
    Kotapati, Srividya
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] An Examination of Patient-Reported Outcomes Data from a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis
    Strand, Vibeke
    Mease, Philip
    Maksabedian, Ervant
    Stolshek, Bradley
    Liu, Lyrica
    Collier, David
    Kricorian, Gregory
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [39] Wild goose chase - no predictable patient subgroups benefit from meniscal surgery: patient-reported outcomes of 641 patients 1 year after surgery
    Pihl, Kenneth
    Ensor, Joie
    Peat, George
    Englund, Martin
    Lohmander, Stefan
    Jorgensen, Uffe
    Nissen, Nis
    Fristed, Jakob Vium
    Thorlund, Jonas Bloch
    BRITISH JOURNAL OF SPORTS MEDICINE, 2020, 54 (01) : 13 - +
  • [40] Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry
    Lala, Anuradha
    Shah, Palak
    Khalatbari, Shokoufeh
    Yosef, Matheos
    Mountis, Maria M.
    Robinson, Shawn W.
    Lanfear, David E.
    Estep, Jerry D.
    Jeffries, Neal
    Taddei-Peters, Wendy C.
    Stevenson, Lynne W.
    Richards, Blair
    Mann, Douglas L.
    Mancini, Donna M.
    Stewart, Garrick C.
    Aaronson, Keith D.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : 765 - 774
12345